PIK3CA and prostate cancer: Co-activation of the RAS/MAPK and PI3K-AKT-mTOR signaling pathways occurs frequently in human malignancies including prostate cancer, thus considerable research has been devoted to establishing how these two oncogenic cascades interact [101,256,257,268,269,270].